Nuclera

👥 101-250💰 $75,000,000 Series C 5 months agoPharmaceuticalBiotechnologyLife Science💼 Private Company
Website LinkedIn Email Twitter

Nuclera is a rapidly growing biotech company revolutionizing protein engineering. We develop and manufacture the eProtein Discovery™ system, a benchtop instrument enabling researchers to produce custom proteins within 48 hours. This accelerates drug discovery and bioengineering processes, offering a significant competitive advantage to our clients in the pharmaceutical and life sciences industries. Our technology integrates seamlessly into existing workflows, providing standardized, next-day protein synthesis. We leverage a robust tech stack including technologies like Google Tag Manager, Google Analytics, and various mobile-friendly development tools to ensure efficient operation and data analysis. Our engineering culture thrives on collaboration and continuous improvement, fostering a dynamic environment where innovation flourishes. We prioritize a supportive and collaborative workplace with excellent benefits, including private medical insurance, enhanced parental leave, and opportunities for professional development. Headquartered in Cambridge, UK, with significant operations in Boston, USA, we're backed by significant venture funding and have achieved substantial growth since our founding in 2013. Nuclera is shaping the future of protein engineering, and we're looking for talented individuals to join our team and contribute to our continued success. Our commitment to accelerating scientific discovery is reflected in our recent Series C funding round of $75 million, underscoring investor confidence in our innovative technology and market leadership. We are a team of talented individuals, with backgrounds in engineering, software development, and the life sciences, all dedicated to empowering researchers with the tools they need to make significant advancements. We are an equal opportunities employer and value diversity within our company.

Related companies: